BACKGROUND/AIMS: Leukocyte adhesion to the endothelium is abnormal in hypertension. We have recently shown that spontaneously hypertensive rats (SHRs) have circulating leukocytes with enhanced CD18 receptor cleavage. In the current study, we investigate expression levels of its counter receptor, intercellular adhesion molecule (ICAM-1), and its possible proteolytic cleavage in the SHR and control Wistar rat. METHODS: ICAM-1 was labeled on tissue sections with two antibodies targeting its extracellular and intracellular domains and evaluated by light absorption measurements. The in situ cleavage of ICAM-1 was assessed by treating vessel sections with matrix metalloproteinase (MMP)-7, MMP-9 and elastase. RESULTS: SHRs showed a significant increase in ICAM-1 expression in liver and kidney compared with Wistar rats. The liver and kidney glomeruli exhibit a discrepancy in label density between intra- and extracellular antibodies, which suggests that enzymatic cleavage may be a factor determining ICAM-1 distribution. MMP-7 and MMP-9, which are elevated in SHR plasma, and elastase, which has elevated activity in SHR neutrophils, cleave the extracellular domain of ICAM-1 when applied to the tissue. CONCLUSION: ICAM-1 expression in SHRs is upregulated in a tissue-specific manner. Proteolytic cleavage of the extracellular domain of ICAM-1 and accumulation in kidney glomeruli may play a role in the renal involvement of inflammation.
BACKGROUND/AIMS: Leukocyte adhesion to the endothelium is abnormal in hypertension. We have recently shown that spontaneously hypertensiverats (SHRs) have circulating leukocytes with enhanced CD18 receptor cleavage. In the current study, we investigate expression levels of its counter receptor, intercellular adhesion molecule (ICAM-1), and its possible proteolytic cleavage in the SHR and control Wistar rat. METHODS:ICAM-1 was labeled on tissue sections with two antibodies targeting its extracellular and intracellular domains and evaluated by light absorption measurements. The in situ cleavage of ICAM-1 was assessed by treating vessel sections with matrix metalloproteinase (MMP)-7, MMP-9 and elastase. RESULTS: SHRs showed a significant increase in ICAM-1 expression in liver and kidney compared with Wistar rats. The liver and kidney glomeruli exhibit a discrepancy in label density between intra- and extracellular antibodies, which suggests that enzymatic cleavage may be a factor determining ICAM-1 distribution. MMP-7 and MMP-9, which are elevated in SHR plasma, and elastase, which has elevated activity in SHR neutrophils, cleave the extracellular domain of ICAM-1 when applied to the tissue. CONCLUSION:ICAM-1 expression in SHRs is upregulated in a tissue-specific manner. Proteolytic cleavage of the extracellular domain of ICAM-1 and accumulation in kidney glomeruli may play a role in the renal involvement of inflammation.
Authors: S Komatsu; J Panés; J M Russell; D C Anderson; V R Muzykantov; M Miyasaka; D N Granger Journal: Hypertension Date: 1997-02 Impact factor: 10.190
Authors: K Shen; K L Sung; D E Whittemore; F A DeLano; B W Zweifach; G W Schmid-Schönbein Journal: Biochem Cell Biol Date: 1995 Jul-Aug Impact factor: 3.626
Authors: M Suematsu; H Suzuki; T Tamatani; Y Iigou; F A DeLano; M Miyasaka; M J Forrest; R Kannagi; B W Zweifach; Y Ishimura Journal: J Clin Invest Date: 1995-10 Impact factor: 14.808
Authors: Geou-Yarh Liou; Heike Döppler; Brian Necela; Brandy Edenfield; Lizhi Zhang; David W Dawson; Peter Storz Journal: Cancer Discov Date: 2014-10-31 Impact factor: 39.397
Authors: Shubha Murthy; Sankar Baruah; Jayden L Bowen; Kathy Keck; Brett A Wagner; Garry R Buettner; David B Sykes; Julia Klesney-Tait Journal: J Leukoc Biol Date: 2022-01-24 Impact factor: 6.011